At The Science Support, we understand the challenges of continuous bioprocessing and proudly offer Cytiva’s ÄKTA protein purification systems—a proven solution designed to optimize continuous downstream processing. As biomanufacturing shifts toward continuous bioprocessing, companies seek solutions that enhance efficiency, reduce costs, and maintain high product consistency. However, in protein purification, the transition from batch to continuous processing introduces significant challenges, including scalability, automation, and real-time process control.
In this article, we explore the key hurdles in protein purification and how the ÄKTA systems help overcome them.
Challenge 1: Maintaining Product Consistency in Continuous Processing
One of the biggest challenges in continuous bioprocessing is ensuring consistent product quality across extended production runs. Unlike batch processing, where each run is isolated, continuous processing introduces the risk of variability due to minor fluctuations in process parameters.
How the ÄKTA System Solves It
Cytiva’s ÄKTA chromatography systems integrate real-time monitoring and automation, ensuring that protein purity, yield, and quality remain stable throughout the process. With advanced gradient control and multi-column chromatography, ÄKTA systems enable high-resolution separation and purification, reducing batch-to-batch variability.
Challenge 2: Process Control and Automation in Continuous Purification
Scaling continuous purification requires precise flow control, pressure management, and automation to handle long, uninterrupted processing times. Without real-time adjustments, deviations in buffer composition or column loading can lead to impurities and loss of product (Shukla & Gottschalk, 2013).
How the ÄKTA System Solves It
The ÄKTA system’s intelligent process automation allows for real-time process adjustments, maintaining optimal conditions throughout purification. Its integration with UNICORN software provides data tracking, method control, and remote monitoring, ensuring seamless operation and reproducibility at an industrial scale.
Challenge 3: Scalability from Process Development to Commercial Production
Many labs struggle with scaling continuous purification from R&D to commercial manufacturing. Traditional purification systems often lack modular scalability, making it difficult to transition from small-scale development to high-volume production.
How the ÄKTA System Solves It
Cytiva’s ÄKTA systems offer a broad range of solutions—from ÄKTA pure for development to ÄKTA process for commercial-scale production. Their scalable design ensures seamless technology transfer without compromising performance, helping biomanufacturers accelerate process validation and regulatory approval.
Conclusion: The Science Support Delivers Cutting-Edge Protein Purification Solutions
As a trusted distributor of Cytiva’s bioprocessing solutions, we, at The Science Support, help biopharmaceutical companies overcome protein purification challenges in continuous processing. Whether optimizing real-time monitoring, improving process automation, or ensuring scalable purification, the ÄKTA system delivers unparalleled consistency, automation, and efficiency.
For more information on how we can enhance your continuous bioprocessing workflows for biopharmaceutical applications, explore our complete suite of integrated solutions.
References:
- Shukla, A. A., & Gottschalk, U. (2013). Single-use disposable technologies for biopharmaceutical manufacturing. Trends in Biotechnology, 31(3), 147-154. DOI: 10.1016/j.tibtech.2012.10.004